Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Ventilatory Modes01:14

Ventilatory Modes

Mechanical ventilators are life-saving devices that support or replace spontaneous breathing. They deliver breaths to patients through varying methods known as ventilator modes. Understanding these modes is critical for healthcare providers managing patients with respiratory failure.
There are three ventilatory modes: full support, partial support, and spontaneous. These are described below.
Full Support Modes
Full support modes include controlled mechanical ventilation, continuous mandatory...
Community Based Intervention01:30

Community Based Intervention

Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Mechanical Ventilation III: Noninvasive Ventilation01:23

Mechanical Ventilation III: Noninvasive Ventilation

Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation (NIPPV)

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative Pulmonary Artery Pressure Response between Large-Bore Thrombectomy and Catheter-Directed Thrombolysis in Patients with Intermediate-High- and High-Risk Pulmonary Embolism.

Journal of vascular and interventional radiology : JVIR·2026
Same author

Wearable-Echo-FM: an ECG echo foundation model for 1-lead electrocardiography.

European heart journal. Digital health·2026
Same author

Paradoxical Embolization in Untreated Recurrent Pulmonary Arteriovenous Malformations: Incidence and Risk Factors.

Journal of vascular and interventional radiology : JVIR·2026
Same author

Five-year survival after large-bore mechanical thrombectomy for intermediate-high and high-risk pulmonary embolism: a single-center cohort.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Clinical Spectrum of Hereditary Hemorrhagic Telangiectasia: Data from the Comprehensive HHT Outcomes Registry of the US (CHORUS).

Blood·2026
Same author

Impact of an Artificial Intelligence-Guided Pulmonary Embolism Response Team (AIPERT) on Patient Transfers, Diagnosis, and Management: A Healthcare System Experience.

Clinics and practice·2025

Related Experiment Video

Updated: Jun 16, 2026

A Modified Technique for Arteriovenous Fistula Construction in Rabbits
05:00

A Modified Technique for Arteriovenous Fistula Construction in Rabbits

Published on: February 10, 2023

1.3K

Criteria for PAVM Reintervention.

Adam Fish1, Elizabeth Knight1, Katharine Henderson1

  • 1Department of Interventional Radiology, Yale School of Medicine, New Haven, CT 06520, USA.

Journal of Clinical Medicine
|October 26, 2024
PubMed
Summary
This summary is machine-generated.

New criteria for retreatment of pulmonary arteriovenous malformations (PAVMs) effectively prevent paradoxical embolization. This study proposes guidelines for PAVM reintervention, ensuring patient safety after embolization procedures.

Keywords:
PAVM paradoxical embolizationPAVM recurrencePAVM reinterventionhereditary hemorrhagic telangiectasia

More Related Videos

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
14:58

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Published on: October 20, 2017

9.6K
A Novel Murine Model of Arteriovenous Fistula Failure: The Surgical Procedure in Detail
10:10

A Novel Murine Model of Arteriovenous Fistula Failure: The Surgical Procedure in Detail

Published on: February 3, 2016

13.0K

Related Experiment Videos

Last Updated: Jun 16, 2026

A Modified Technique for Arteriovenous Fistula Construction in Rabbits
05:00

A Modified Technique for Arteriovenous Fistula Construction in Rabbits

Published on: February 10, 2023

1.3K
Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
14:58

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Published on: October 20, 2017

9.6K
A Novel Murine Model of Arteriovenous Fistula Failure: The Surgical Procedure in Detail
10:10

A Novel Murine Model of Arteriovenous Fistula Failure: The Surgical Procedure in Detail

Published on: February 3, 2016

13.0K

Area of Science:

  • Vascular Surgery
  • Interventional Radiology
  • Pulmonary Medicine

Background:

  • Pulmonary arteriovenous malformations (PAVMs) are abnormal connections between pulmonary arteries and veins.
  • Embolization is a common treatment for PAVMs, but recurrence and paradoxical embolization are potential complications.
  • Establishing clear criteria for reintervention is crucial for managing recurrent PAVMs and preventing adverse events.

Purpose of the Study:

  • To propose and evaluate criteria for re-treating previously embolized PAVMs.
  • To determine the effectiveness of these criteria in preventing paradoxical embolization.
  • To refine management strategies for patients with PAVMs and hereditary hemorrhagic telangiectasia (HHT).

Main Methods:

  • Retrospective review of 151 patients with PAVMs treated between 2013 and 2023.
  • Analysis of PAVM recurrence and reintervention based on defined criteria (channel size, accessory vessels, hemoptysis).
  • Assessment of paradoxical embolization rates pre- and post-treatment.

Main Results:

  • PAVM recurrence was observed in 23.8% of patients (36/151).
  • 5.0% of treated PAVMs (22/438) met criteria for reintervention.
  • No cases of post-treatment paradoxical embolization occurred in 151 patients.

Conclusions:

  • The proposed reintervention criteria are effective in preventing paradoxical embolization after PAVM embolization.
  • Modern embolization techniques and defined screening intervals enhance treatment safety.
  • These criteria provide a framework for optimal management of recurrent PAVMs.